Skip to main content
SpringerLink
Log in

Obesity and Metabolic Syndrome After Childhood and Adolescent Cancer

  • Chapter
  • First Online:
Late Treatment Effects and Cancer Survivor Care in the Young

Abstract

Obesity and an increased risk of developing diabetes mellitus and cardiovascular disease are common late complications of childhood and adolescent cancer, but as such are often detected late and receive inadequate treatment [1]. Increased morbidity due to cardiovascular disease is a major burden for this growing patient population and leads to reduced quality of life and excessive mortality [2–4].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Mostoufi-Moab S, et al. Endocrine abnormalities in aging survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol. 2016;34:3240–7.

    Article  Google Scholar 

  2. Armstrong GT, et al. Late mortality among 5-year survivors of childhood cancer: a summary from the childhood cancer survivor study. J Clin Oncol. 2009;27:2328–38.

    Article  CAS  Google Scholar 

  3. Mertens AC, et al. Cause-specific late mortality among 5-year survivors of childhood cancer: the childhood cancer survivor study. J Natl Cancer Inst. 2008;100:1368–79.

    Article  Google Scholar 

  4. Rugbjerg K, et al. Cardiovascular disease in survivors of adolescent and young adult cancer: a Danish cohort study, 1943-2009. J Natl Cancer Inst. 2014;106:dju110.

    Article  Google Scholar 

  5. Meacham LR, et al. Body mass index in long-term adult survivors of childhood cancer: a report of the childhood cancer survivor study. Cancer. 2005;103:1730–9.

    Article  Google Scholar 

  6. Zhang FF, et al. Obesity in pediatric ALL survivors: a meta-analysis. Pediatrics. 2014;133:e704–15.

    Article  Google Scholar 

  7. Janiszewski PM, et al. Abdominal obesity, liver fat, and muscle composition in survivors of childhood acute lymphoblastic leukemia. J Clin Endocrinol Metab. 2007;92:3816–21.

    Article  CAS  Google Scholar 

  8. Murphy AJ, et al. Body composition of children with cancer during treatment and in survivorship. Am J Clin Nutr. 2015;102:891–6.

    Article  CAS  Google Scholar 

  9. Nysom K, et al. Degree of fatness after allogeneic BMT for childhood leukaemia or lymphoma. Bone Marrow Transplant. 2001;27:817–20.

    Article  CAS  Google Scholar 

  10. Nysom K, et al. Degree of fatness after treatment of malignant lymphoma in childhood. Med Pediatr Oncol. 2003;40:239–43.

    Article  Google Scholar 

  11. Tonorezos ES, et al. Adipokines, body fatness, and insulin resistance among survivors of childhood leukemia. Pediatr Blood Cancer. 2011;58:31–6.

    Article  Google Scholar 

  12. Blijdorp K, et al. Obesity is underestimated using body mass index and waist-hip ratio in long-term adult survivors of childhood cancer. PLoS One. 2012;7:e43269.

    Article  CAS  Google Scholar 

  13. Karlage RE, et al. Validity of anthropometric measurements for characterizing obesity among adult survivors of childhood cancer: a report from the St. Jude Lifetime Cohort Study. Cancer. 2015;121:2036–43.

    Article  Google Scholar 

  14. Brennan BM, et al. Hyperleptinaemia in young adults following cranial irradiation in childhood: growth hormone deficiency or leptin insensitivity. Clin Endocrinol. 1999;50:163–9.

    Article  CAS  Google Scholar 

  15. Reilly JJ, et al. Effect of glucocorticoid therapy on energy intake in children treated for acute lymphoblastic leukemia. J Clin Endocrinol Metab. 2001;86:3742–5.

    Article  CAS  Google Scholar 

  16. Hocking MC, et al. Prospectively examining physical activity in young adult survivors of childhood cancer and healthy controls. Pediatr Blood Cancer. 2013;60:309–15.

    Article  Google Scholar 

  17. Hoos MB, et al. Physical activity as measured by accelerometry in children receiving growth hormone. Acta Paediatr. 2004;93:1307–11.

    Article  CAS  Google Scholar 

  18. Robien K, et al. Poor adherence to dietary guidelines among adult survivors of childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2008;30:815–22.

    Article  Google Scholar 

  19. Green DM, et al. Risk factors for obesity in adult survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol. 2012;30:246–55.

    Article  Google Scholar 

  20. Wilson CL, et al. Genetic and clinical factors associated with obesity among adult survivors of childhood cancer: a report from the St. Jude lifetime cohort. Cancer. 2015;121:2262–70.

    Article  CAS  Google Scholar 

  21. Bereket A, et al. Hypothalamic obesity in children. Obes Rev. 2012;13:780–98.

    Article  CAS  Google Scholar 

  22. Lustig RH. Hypothalamic obesity: causes, consequences, treatment. Pediatr Endocrinol Rev. 2008;6:220–7.

    Google Scholar 

  23. Garmey EG, et al. Longitudinal changes in obesity and body mass index among adult survivors of childhood acute lymphoblastic leukemia: a report from the childhood Cancer survivor study. J Clin Oncol. 2008;26:4639–45.

    Article  Google Scholar 

  24. Groot-Loonen JJ, et al. Influence of treatment modalities on body weight in acute lymphoblastic leukemia. Med Pediatr Oncol. 1996;27:92–7.

    Article  CAS  Google Scholar 

  25. Oeffinger KC, et al. Obesity in adult survivors of childhood acute lymphoblastic leukemia: a report from the childhood cancer survivor study. J Clin Oncol. 2003;21:1359–65.

    Article  Google Scholar 

  26. Sklar CA, et al. Changes in body mass index and prevalence of overweight in survivors of childhood acute lymphoblastic leukemia: role of cranial irradiation. Med Pediatr Oncol. 2000;35:91–5.

    Article  CAS  Google Scholar 

  27. Chow EJ, et al. Obesity and hypertension among children after treatment for acute lymphoblastic leukemia. Cancer. 2007;110:2313–20.

    Article  Google Scholar 

  28. Karakurt H, et al. Screening survivors of childhood acute lymphoblastic leukemia for obesity, metabolic syndrome, and insulin resistance. Pediatr Hematol Oncol. 2012;29:551–61.

    Article  CAS  Google Scholar 

  29. Nathan PC, et al. The prevalence of overweight and obesity in pediatric survivors of cancer. J Pediatr. 2006;149:518–25.

    Article  Google Scholar 

  30. Reilly JJ, et al. Risk factors for excess weight gain in children treated for acute lymphoblastic leukaemia. Int J Obes Relat Metab Disord. 2000;24:1537–41.

    Article  CAS  Google Scholar 

  31. Withycombe JS, et al. Weight patterns in children with higher risk ALL: a report from the children’s oncology group (COG) for CCG 1961. Pediatr Blood Cancer. 2009;53:1249–54.

    Article  Google Scholar 

  32. Gurney JG, et al. Final height and body mass index among adult survivors of childhood brain cancer: childhood cancer survivor study. J Clin Endocrinol Metab. 2003;88:4731–9.

    Article  CAS  Google Scholar 

  33. Ross JA, et al. Genetic variation in the leptin receptor gene and obesity in survivors of childhood acute lymphoblastic leukemia: a report from the childhood cancer survivor study. J Clin Oncol. 2004;22:3558–62.

    Article  CAS  Google Scholar 

  34. Atkinson HC, et al. Increased body mass index during therapy for childhood acute lymphoblastic leukemia: a significant and underestimated complication. Int J Pediatr. 2015;2015:386413.

    Article  Google Scholar 

  35. Zhang FF, et al. Predictors of being overweight or obese in survivors of pediatric acute lymphoblastic leukemia (ALL). Pediatr Blood Cancer. 2014;61:1263–9.

    Article  Google Scholar 

  36. Zhang FF, et al. Growth patterns during and after treatment in patients with pediatric ALL: a meta-analysis. Pediatr Blood Cancer. 2015;62:1452–60.

    Article  Google Scholar 

  37. Withycombe JS, et al. Weight change during childhood acute lymphoblastic leukemia induction therapy predicts obesity: a report from the children’s oncology group. Pediatr Blood Cancer. 2015;62:434–9.

    Article  Google Scholar 

  38. Florin TA, et al. Physical inactivity in adult survivors of childhood acute lymphoblastic leukemia: a report from the childhood cancer survivor study. Cancer Epidemiol Biomark Prev. 2007;16:1356–63.

    Article  Google Scholar 

  39. Ness KK, et al. Physical performance limitations in the childhood cancer survivor study cohort. J Clin Oncol. 2009;27:2382–9.

    Article  Google Scholar 

  40. Ness KK, et al. Predictors of inactive lifestyle among adult survivors of childhood cancer: a report from the childhood cancer survivor study. Cancer. 2009;115:1984–94.

    Article  Google Scholar 

  41. Jarvela LS, et al. Physical activity and fitness in adolescent and young adult long-term survivors of childhood acute lymphoblastic leukaemia. J Cancer Surviv. 2010;4:339–45.

    Article  Google Scholar 

  42. Tonorezos ES, et al. Reduced cardiorespiratory fitness in adult survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2013;60:1358–64.

    Article  Google Scholar 

  43. van Brussel M, et al. Is physical fitness decreased in survivors of childhood leukemia? A systematic review. Leukemia. 2005;19:13–7.

    Article  Google Scholar 

  44. Svensson J, et al. Three-years of growth hormone (GH) replacement therapy in GH-deficient adults: effects on quality of life, patient-reported outcomes and healthcare consumption. Growth Hormon IGF Res. 2004;14:207–15.

    Article  CAS  Google Scholar 

  45. Oeffinger KC. Are survivors of acute lymphoblastic leukemia (ALL) at increased risk of cardiovascular disease? Pediatr Blood Cancer. 2008;50:462–7. discussion 468

    Article  Google Scholar 

  46. Wright MJ, et al. Proficiency of balance in children and youth who have had acute lymphoblastic leukemia. Phys Ther. 2005;85:782–90.

    Article  Google Scholar 

  47. Wright MJ, et al. Long-term gross motor performance following treatment for acute lymphoblastic leukemia. Med Pediatr Oncol. 1998;31:86–90.

    Article  CAS  Google Scholar 

  48. Ness KK, et al. Energy balance and fitness in adult survivors of childhood acute lymphoblastic leukemia. Blood. 2015;125:3411–9.

    Article  CAS  Google Scholar 

  49. Mayer EI, et al. Energy expenditure, energy intake and prevalence of obesity after therapy for acute lymphoblastic leukemia during childhood. Horm Res. 2000;53:193–9.

    CAS  Google Scholar 

  50. Reilly JJ, et al. Reduced energy expenditure in preobese children treated for acute lymphoblastic leukemia. Pediatr Res. 1998;44:557–62.

    Article  CAS  Google Scholar 

  51. Zhang FF, et al. Low levels of energy expenditure in childhood cancer survivors: implications for obesity prevention. J Pediatr Hematol Oncol. 2015;37:232–6.

    Article  CAS  Google Scholar 

  52. Muller HL. Childhood craniopharyngioma—current concepts in diagnosis, therapy and follow-up. Nat Rev Endocrinol. 2010;6:609–18.

    Article  Google Scholar 

  53. Hochberg I, Hochberg Z. Expanding the definition of hypothalamic obesity. Obes Rev. 2010;11:709–21.

    Article  CAS  Google Scholar 

  54. Gurney JG, et al. Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: childhood cancer survivor study. Cancer. 2003;97:663–73.

    Article  Google Scholar 

  55. Lustig RH, et al. Risk factors for the development of obesity in children surviving brain tumors. J Clin Endocrinol Metab. 2003;88:611–6.

    Article  CAS  Google Scholar 

  56. Greenfield DM, et al. Endocrine, metabolic, nutritional and body composition abnormalities are common in advanced intensively-treated (transplanted) multiple myeloma. Bone Marrow Transplant. 2014;49:907–12.

    Article  CAS  Google Scholar 

  57. Kyle UG, et al. Longitudinal follow-up of body composition in hematopoietic stem cell transplant patients. Bone Marrow Transplant. 2005;35:1171–7.

    Article  CAS  Google Scholar 

  58. Mostoufi-Moab S, et al. Body composition abnormalities in long-term survivors of pediatric hematopoietic stem cell transplantation. J Pediatr. 2012;160:122–8.

    Article  Google Scholar 

  59. Chao C, et al. Cardiovascular disease risk profiles in survivors of adolescent and young adult (AYA) cancer: the Kaiser Permanente AYA cancer survivors study. J Clin Oncol. 2016;34:1626–33.

    Article  CAS  Google Scholar 

  60. Adams MJ, Lipshultz SE. Pathophysiology of anthracycline- and radiation-associated cardiomyopathies: implications for screening and prevention. Pediatr Blood Cancer. 2005;44:600–6.

    Article  Google Scholar 

  61. Herrmann J, et al. Vascular toxicities of cancer therapies: the old and the new—an evolving avenue. Circulation. 2016;133:1272–89.

    Article  CAS  Google Scholar 

  62. Nottage KA, et al. Metabolic syndrome and cardiovascular risk among long-term survivors of acute lymphoblastic leukaemia—from the St. Jude lifetime cohort. Br J Haematol. 2014;165:364–74.

    Article  CAS  Google Scholar 

  63. Laaksonen DE, et al. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol. 2002;156:1070–7.

    Article  Google Scholar 

  64. Lakka HM, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:2709–16.

    Article  Google Scholar 

  65. Gurney JG, et al. Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia. Cancer. 2006;107:1303–12.

    Article  CAS  Google Scholar 

  66. Taskinen M, et al. Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood. Lancet. 2000;356:993–7.

    Article  CAS  Google Scholar 

  67. Rosen GP, et al. Metabolic syndrome in pediatric cancer survivors: a mechanistic review. Pediatr Blood Cancer. 2013;60:1922–8.

    Article  Google Scholar 

  68. Oeffinger KC, et al. Insulin resistance and risk factors for cardiovascular disease in young adult survivors of childhood acute lymphoblastic leukemia. J Clin Oncol. 2009;27:3698–704.

    Article  CAS  Google Scholar 

  69. Wei C, et al. Reduced insulin sensitivity in childhood survivors of haematopoietic stem cell transplantation is associated with lipodystropic and sarcopenic phenotypes. Pediatr Blood Cancer. 2015;62:1992–9.

    Article  CAS  Google Scholar 

  70. Meacham LR, et al. Diabetes mellitus in long-term survivors of childhood cancer. Increased risk associated with radiation therapy: a report for the childhood cancer survivor study. Arch Intern Med. 2009;169:1381–8.

    Article  Google Scholar 

  71. de Vathaire F, et al. Radiation dose to the pancreas and risk of diabetes mellitus in childhood cancer survivors: a retrospective cohort study. Lancet Oncol. 2012;13:1002–10.

    Article  Google Scholar 

  72. van Nimwegen FA, et al. Risk of diabetes mellitus in long-term survivors of Hodgkin lymphoma. J Clin Oncol. 2014;32:3257–63.

    Article  Google Scholar 

  73. Kavanagh K, et al. Type 2 diabetes is a delayed late effect of whole-body irradiation in nonhuman primates. Radiat Res. 2015;183:398–406.

    Article  CAS  Google Scholar 

  74. Oeffinger KC, Sklar CA. Abdominal radiation and diabetes: one more piece in the puzzle. Lancet Oncol. 2012;13:961–2.

    Article  Google Scholar 

  75. Tonorezos ES, et al. Screening and management of adverse endocrine outcomes in adult survivors of childhood and adolescent cancer. Lancet Diabetes Endocrinol. 2015;3:545–55.

    Article  Google Scholar 

  76. Chow EJ, et al. Increased cardiometabolic traits in pediatric survivors of acute lymphoblastic leukemia treated with total body irradiation. Biol Blood Marrow Transplant. 2010;16:1674–81.

    Article  Google Scholar 

  77. Oudin C, et al. Prevalence and risk factors of the metabolic syndrome in adult survivors of childhood leukemia. Blood. 2011;117:4442–8.

    Article  CAS  Google Scholar 

  78. Hoffmeister PA, et al. Hypertension in long-term survivors of pediatric hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2010;16:515–24.

    Article  CAS  Google Scholar 

  79. Hoffman KE, et al. Metabolic syndrome traits in long-term survivors of pediatric sarcoma. Pediatr Blood Cancer. 2008;50:341–6.

    Article  Google Scholar 

  80. Follin C, et al. Improvement in cardiac systolic function and reduced prevalence of metabolic syndrome after two years of growth hormone (GH) treatment in GH-deficient adult survivors of childhood-onset acute lymphoblastic leukemia. J Clin Endocrinol Metab. 2006;91:1872–5.

    Article  CAS  Google Scholar 

  81. Taskinen M, et al. Insufficient growth hormone secretion is associated with metabolic syndrome after allogeneic stem cell transplantation in childhood. J Pediatr Hematol Oncol. 2007;29:529–34.

    Article  CAS  Google Scholar 

  82. Talvensaari KK, et al. Long-term survivors of childhood cancer have an increased risk of manifesting the metabolic syndrome. J Clin Endocrinol Metab. 1996;81:3051–5.

    CAS  Google Scholar 

  83. Meacham LR, et al. Cardiovascular risk factors in adult survivors of pediatric cancer—a report from the childhood cancer survivor study. Cancer Epidemiol Biomark Prev. 2010;19:170–81.

    Article  Google Scholar 

  84. Mulrooney DA, et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the childhood cancer survivor study cohort. BMJ. 2009;339:b4606.

    Article  Google Scholar 

  85. Olsson DS, et al. Excess mortality and morbidity in patients with craniopharyngioma, especially in patients with childhood onset: a population-based study in Sweden. J Clin Endocrinol Metab. 2015;100:467–74.

    Article  CAS  Google Scholar 

  86. Yuen KCJ, et al. Relative risks of contributing factors to morbidity and mortality in adults with craniopharyngioma on growth hormone replacement. J Clin Endocrinol Metab. 2018;103:768–77.

    Article  Google Scholar 

  87. Bovelli D, et al. Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease: ESMO clinical practice guidelines. Ann Oncol. 2010;21(Suppl 5):v277–82.

    Article  Google Scholar 

  88. Chow EJ, et al. Late effects surveillance recommendations among survivors of childhood hematopoietic cell transplantation: a children’s oncology group report. Biol Blood Marrow Transplant. 2016;22:782–95.

    Article  Google Scholar 

  89. DeFilipp Z, et al. Metabolic syndrome and cardiovascular disease after hematopoietic cell transplantation: screening and preventive practice recommendations from the CIBMTR and EBMT. Biol Blood Marrow Transplant. 2016;22:1493–503.

    Article  Google Scholar 

  90. Denzer C, et al. Endokrinologische Nachsorge nach onkologischen Erkrankungen im Kindes- und Jugendalter. AWMF-Leitlinien-Register 025-030; 2014.

    Google Scholar 

  91. Scottish Intercollegiate Guidelines Network (SIGN). Long term follow up of survivors of childhood cancer. Edinburgh: SIGN; 2013. (SIGN publication no. 132). Available from URL. http://www.sign.ac.uk.

    Google Scholar 

  92. Shankar SM, et al. Monitoring for cardiovascular disease in survivors of childhood cancer: report from the cardiovascular disease task force of the children’s oncology group. Pediatrics. 2008;121:e387–96.

    Article  Google Scholar 

  93. Baker KS, et al. Metabolic syndrome and cardiovascular risk in survivors after hematopoietic cell transplantation. Bone Marrow Transplant. 2012;47:619–25.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pediatric Endocrinology and Diabetes, Interdisciplinary Obesity Unit, Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany

    Christian Denzer

  2. Experimental and Clinical Endocrinology, Med Clinic I—University of Luebeck, Lübeck, Germany

    Judith Gebauer & Georg Brabant

Authors
  1. Christian Denzer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Judith Gebauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Georg Brabant
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christian Denzer .

Editor information

Editors and Affiliations

  1. Department of Pediatrics, University Children’s Hospital, Erlangen, Germany

    Jörn D. Beck

  2. Department of Onkology, University Hospital Hamburg-Eppendorf, Hamburg, Germany

    Carsten Bokemeyer

  3. Pediatric Oncology and Hematology – Long-Term Follow-Up after Childhood Cancer, University Hospital for Children and Adolescents, Lübeck, Germany

    Thorsten Langer

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Denzer, C., Gebauer, J., Brabant, G. (2021). Obesity and Metabolic Syndrome After Childhood and Adolescent Cancer. In: Beck, J.D., Bokemeyer, C., Langer, T. (eds) Late Treatment Effects and Cancer Survivor Care in the Young. Springer, Cham. https://doi.org/10.1007/978-3-030-49140-6_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-49140-6_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-49138-3

  • Online ISBN: 978-3-030-49140-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation